Intelligence Platform
Patents
Browse 980 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 8263632
Aminopyridine derivatives having Aurora A selective inhibitory action
granted patentUS 8263605
Modulators of muscarinic receptors
granted patentUS 8258148
Spiroindoline modulators of muscarinic receptors
granted patentUS 8258116
Combination therapy for the treatment of HCV infection
granted patentUS 8252923
Peptidomimetic protease inhibitors
granted patentUS 8252787
Protein kinase inhibitors
granted patentUS 8252541
Sodium channel protein type III Ξ±-subunit splice variant
granted patentUS 8247421
5-cyano-4-(pyrrolo [2,3B] pyridine-3-yl)-pyrimidine derivatives useful as protein kinase i
granted patentUS 8247532
Deuterated hepatitis C protease inhibitors
granted patentUS 8242149
Modulators of ATP-binding cassette transporters
granted patentUS 8242272
Process for preparing 5-fluoro-1H-pyrazolo [3,4-B] pyridin-3-amine and derivatives thereof
granted patentUS 8236833
Biphenyl derivatives as modulators of voltage gated ion channels
granted patentUS 8236815
Ion channel modulators and methods of uses
granted patentUS 8236829
Bicyclic derivatives as modulators of voltage gated ION channels
granted patentUS 8236832
Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases
granted patentUS 8232302
Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters
granted patentUS 8232406
c-MET protein kinase inhibitors
granted patentUS 8227615
Pyridyl derivatives as CFTR modulators
granted patentUS 8217048
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
granted patentUS 8217172
Solid forms of 1-ethyl-3-(5-(5-fluoropyridin-3-yl)-7-(pyrimidin-2-yl)-1H-benzo[d]imidazol-
granted patentUS 8217056
Triazolothiadiazole inhibitor of c-Met protein kinase
granted patentUS 8211935
Heterocyclic derivatives for modulation of calcium channels
granted patentUS 8202889
Inhibitors of bacterial IMPDH
granted patentUS 8202861
Compositions useful as inhibitors of voltage-gated sodium channels
granted